Add BrightSurf on Google Email

Science News Archive June 2016 - Page 37


Page 37 of 40

Detecting an early biomarker for pancreatic cancer in blood

Researchers identify human satellite II (HSATII) RNA as a promising early detection method for pancreatic cancer, with significantly higher levels found in patients' blood serum. A pilot study validated the test's ability to detect pancreatic cancer and a precancerous lesion in two cohorts of patients.

SourceJCI Journals·JournalJCI Insight·DateJun 2, 2016

$10 million endowment for health disparities work

San Diego State University has received a $10 million endowment from the National Institutes of Health to improve its research infrastructure and support population health and health disparities research. The funding will enable researchers to collaborate across disciplines and institutions, fostering innovations in research programs w...

Use of neighborhood environment can help overweight adolescents increase physical activity

A pilot study at Massachusetts General Hospital found that using everyday environments to increase physical activity led to significant gains in daily activity. Adolescents who participated in the program showed a 7.7-minute increase in moderate-to-vigorous activity, compared to half a minute for control group participants.

SourceMassachusetts General Hospital·JournalJournal of Adolescent Health·DateJun 2, 2016

A new energy source within the cells

Researchers at Center for Genomic Regulation discover a new pathway generating energy in the cell nucleus to deal with stressful situations and high levels of DNA damage. The key enzyme NUDIX5 is identified as crucial for nuclear ATP synthesis, which could lead to targeted cancer medicine and biomarker development.

SourceCenter for Genomic Regulation·JournalScience·DateJun 2, 2016

New free web service for deep study of cell functions

GAM is a free web service that identifies links between changes in metabolism and genes, enabling better understanding of complex biological processes. The program can analyze entire maps of metabolic pathways in cells, revealing mechanisms of tumor growth and shedding light on autoimmune pathologies.

SourceITMO University·JournalNucleic Acids Research·DateJun 2, 2016

Two-drug immunotherapy deemed safe for lung cancer patients, Moffitt study shows

A Moffitt Cancer Center study found that combining nivolumab and ipilimumab is an active treatment option for small cell lung cancer patients who have failed initial therapy. The two-drug immunotherapy regimen resulted in responses that lasted longer than many other investigational agents, with 20% of patients showing a response.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalThe Lancet Oncology·DateJun 2, 2016